- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 351.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 353.25M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 344.72M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $532.42M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $399.09M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.43B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.45B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $23.37B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $22.93B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $23.46B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $24.56B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $48.86B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $49.41B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.46 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.30 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $154.76M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $123.54M |
| Net Income | Q1 2026 · Mar 31, 2026 | $179.27M |
| Net Income | Q1 2026 · Mar 31, 2025 | $109.97M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $267.81M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $196.86M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.64B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.41B |